Tecnotree Q3 EBIT jumps 59% year over year to EUR 5.8 million; Q3 revenue rises 8% to EUR 20.2 million year over year
Bitget2026/10/28 07:14- Tecnotree’s Q3 net income fell 14% year-on-year to EUR 3 million; revenue rose 8% to EUR 20.2 million.
- Q3 EBIT jumped 59% year-on-year to EUR 5.8 million, while operating costs declined to EUR 14.6 million.
- Q3 free cash flow climbed 54% year-on-year to EUR 1.8 million, marking the tenth consecutive positive quarter.
- An existing Tier-1 customer in the Americas signed a three-year ARR agreement worth around USD 17.5 million in August.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Media & Technology Group plunges over 24%, hitting a new low since listing.
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.